🇨🇦 Zoledronic acid in combination with therapy in Canada

Zoledronic acid in combination with therapy (Zoledronic acid in combination with therapy) regulatory status in Canada.

Marketing authorisation

Zoledronic acid in combination with therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Zoledronic acid in combination with therapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Zoledronic acid in combination with therapy in Canada?

Novartis Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.